Skip to content

Wearable Health Solutions, Inc.: financial reference

Explore Wearable Health Solutions, Inc. financial histories from SEC filings, with original units, reporting periods, filing dates and downloadable source data.

Filing record ends 2023-10-20

The latest filing in this captured record is a 10-K filed 2023-10-20. No later filing is in the SEC companyfacts record captured on 2026-09-22. Wearable Health Solutions, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Reported financial histories

Choose a measure to inspect its definition, complete selected history and filing provenance. Each row shows the latest period available for that selected concept and original unit. Separate currencies and reporting intervals remain separate rows. Coverage dates can differ between concepts. A recent capture does not imply recent accounting coverage; these amounts are not prices.

Latest periods by selected concept and original unit
MeasurePeriod startPeriod endValueUnitFiled
Total assets-2023-06-30223,173USD2023-10-20
Total liabilities-2023-06-303,800,285USD2023-10-20
Stockholders equity-2023-06-30-3,577,112USD2023-10-20
Cash and cash equivalents-2019-06-303,828USD2020-06-03
Net income or loss2022-07-012023-06-30-2,388,467USD2023-10-20
Operating cash flow2022-07-012023-06-30-1,279,472USD2023-10-20
Capital expenditure payments2022-07-012023-06-309,442USD2023-10-20
Revenue2022-07-012023-06-30745,093USD2023-10-20
Financing cash flow2022-07-012023-06-301,354,560USD2023-10-20
Investing cash flow2022-07-012023-06-30-9,442USD2023-10-20
Retained earnings or deficit-2023-06-30-41,811,849USD2023-10-20
Basic weighted-average shares2022-07-012023-06-301,535,831,375shares2023-10-20
Diluted weighted-average shares2022-07-012023-06-301,535,831,375shares2023-10-20
Basic earnings per share2022-07-012023-06-30-0.00156USD/shares2023-10-20
Diluted earnings per share2022-07-012023-06-30-0.00156USD/shares2023-10-20
Net property, plant and equipment-2023-06-3038,689USD2023-10-20
Share-based compensation expense2022-07-012023-06-30294,360USD2023-10-20
Operating income or loss2022-07-012023-06-30-2,294,141USD2023-10-20
Current assets-2023-06-30152,327USD2023-10-20
Interest expense2022-07-012023-06-3010,800USD2023-10-20
Current liabilities-2023-06-303,781,817USD2023-10-20
Current accounts payable-2023-06-30162,936USD2023-10-20
Net current accounts receivable-2023-06-30379USD2023-10-20
Operating expenses2022-07-012023-06-302,561,804USD2023-10-20
Net inventory-2023-06-308,555USD2023-10-20
Gross profit2022-07-012023-06-30267,663USD2023-10-20
Cost of revenue2022-07-012023-06-30477,430USD2023-10-20
Research and development expense2022-07-012023-06-3049,680USD2023-10-20
Common shares outstanding-2023-06-301,566,255,108shares2023-10-20
Cash including restricted cash-2023-06-30136,151USD2023-10-20
Additional paid-in capital-2023-06-3037,472,648USD2023-10-20
Gross property, plant and equipment-2023-06-30145,032USD2023-10-20
Accumulated depreciation on property, plant and equipment-2023-06-30106,343USD2023-10-20
Net intangible assets excluding goodwill-2014-06-301,099,036USD2015-12-18
Accrued current liabilities-2016-06-3025,653USD2023-10-20
Current contract liabilities-2023-06-30103,412USD2023-10-20
Pre-tax income or loss from continuing operations2022-07-012023-06-30-2,388,467USD2023-10-20
Profit or loss including noncontrolling interests2018-07-012019-06-30-417,107USD2020-06-03
General and administrative expense2022-07-012023-06-30348,281USD2023-10-20
Depreciation expense2022-07-012023-06-3012,404USD2023-10-20
Amortization of intangible assets2012-07-012013-06-3078,503USD2014-07-17
Nonoperating income or expense2022-07-012023-06-30-94,326USD2023-10-20
Interest paid, net2022-07-012023-06-300USD2023-10-20
Proceeds from issuing common stock2022-07-012023-06-30819,500USD2023-10-20
Change in accounts receivable2022-07-012023-06-30-1,621USD2023-10-20
Change in inventories2022-07-012023-06-301,491USD2023-10-20
Change in accounts payable2018-07-012019-06-30129,166USD2020-06-03

Filings

48 Wearable Health Solutions filings with published measures: what each annual or quarterly report tagged, with the periods it covered, as reported in that filing. The histories above show the latest-filed value per period.

Inspect the source

Entity
Wearable Health Solutions, Inc. / CIK 0001443089
Captured
SEC response SHA-256
2968f75b249337514377a8e6acab9c4dc9cfeb14de9a999cfee99420111c5b81

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001443089.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))